Format

Send to

Choose Destination
Lancet Oncol. 2009 Nov;10(11):1111-8. doi: 10.1016/S1470-2045(09)70241-4.

Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009.

Author information

1
National Cancer Centre, Singapore; Duke-NUS Graduate Medical School, Singapore. dmopyh@nccs.com.sg

Abstract

Asia has a disproportionately large share of the world's hepatocellular carcinoma (HCC), mainly because of the endemic status of chronic hepatitis B and C viruses, which leads to liver cirrhosis and an increased risk of HCC. This etiological factor presents important opportunities for prevention, early detection, diagnosis, and treatment of HCC. This consensus statement reviews the available medical evidence for management of HCC in Asia, and gives treatment recommendations that are adapted to resource availability in this diverse region with disparate health-care delivery systems.

PMID:
19880065
DOI:
10.1016/S1470-2045(09)70241-4
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center